4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0000899243-20-005665
Chairman sold 23,318 shares at $64.90 ($1,513,338)
- Chairman acquired 23,318 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| El-Hibri Fuad Chairman | 2020-02-20 | Option exercise | +4,751 | $25.62 | $121,721 | 1,483,769 | D |
| El-Hibri Fuad Chairman | 2020-02-20 | Sale | −4,751 | $64.90 | $308,340 | 1,479,018 | D |
| El-Hibri Fuad Chairman | 2020-02-21 | Option exercise | +18,567 | $25.62 | $475,687 | 1,497,585 | D |
| El-Hibri Fuad Chairman | 2020-02-21 | Sale | −18,567 | $64.90 | $1,204,998 | 1,479,018 | D |
| Derivatives | |||||||
| El-Hibri Fuad Chairman | 2020-02-20 | Option exercise · Employee Stock Options (Right to Buy) | −4,751 | 18,567 | D | ||
| El-Hibri Fuad Chairman | 2020-02-21 | Option exercise · Employee Stock Options (Right to Buy) | −18,567 | 0 | D | ||
| Open-market sales · 23,318 sh · avg $64.90 · $1,513,338 | |||||||
Loading xslF345X03/doc4.xml…